TC BioPharm (Holdings) plc Warrants
TCBPW
TCBPW was delisted on the 21st of March, 2025.
5 hedge funds and large institutions have $32.7K invested in TC BioPharm (Holdings) plc Warrants in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
7% more capital invested
Capital invested by funds: $30.6K → $32.7K (+$2.15K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$251 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.41K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $20K | +$29.6K | +470,588 | New |
|
|
NCM
2
Nantahala Capital Management
New Canaan,
Connecticut
| $10.1K | – | – | – |
|
|
AC
3
Armistice Capital
New York
| $1.62K | – | -1 | -0% |
|
|
ACM
4
Altium Capital Management
New York
| $809 | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $180 | +$251 | +3,985 | +1,993% |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.41K | -14,174 | Closed |
|
TCBPW Hedge Fund Activity: Q2 2023 in Review
5 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q2 2023, worth a combined $32.7K — up 7% from $30.6K a quarter earlier.
Fund positioning in TCBPW was balanced in Q2 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, adding an estimated $251. The largest seller was Susquehanna International Group, exiting entirely with an estimated $1.41K sold.
- 5 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $32.7K of TC BioPharm (Holdings) plc Warrants stock for Q2 2023, up 7% quarter-over-quarter.
- 1 fund opened new TC BioPharm (Holdings) plc Warrants positions in Q2 2023 and 1 closed out, a net change of 0 holders.
- The largest TC BioPharm (Holdings) plc Warrants buyer in Q2 2023 was UBS Group, an estimated $251 added.
- The largest TC BioPharm (Holdings) plc Warrants seller in Q2 2023 was Susquehanna International Group, an estimated $1.41K sold.
Based on aggregated 13F filings for Q2 2023.